CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 10 No. 3
The Mendenhall/Parsons/Siemann Article Reviewed 

Does Neck Stage Predict Local Control After Irradiation for Head and Neck Cancer?

By

William F. Regine, MD, and Mohammed Mohiuddin, MD, University of Kentucky Medical Center, Lexington | March 1, 1996


The article by Mendenhall et al represents a comprehensive review of their own experience, as well as other large experiences in the literature, aimed at addressing the controversy of whether neck stage predicts local control after irradiation of head and neck cancer. The authors systematically explore this controversy in the setting of both definitive and postoperative therapy. Based on this review, and our own experience, we conclude that there are no significant data showing a correlation between neck stage and local control at the primary tumor site following irradiation of head and neck carcinoma.

In the Setting of Definitive Therapy

Does neck stage predict local control after definitive irradiation alone? The authors present the results of 11 reviews, including over 4,000 patients with head and neck cancer, that have addressed this question. Of the 11 series, 9 showed no correlation between neck stage and local control after primary irradiation.

The two series that did show a correlation were the Wall et al experience in patients with carcinomas of the supraglottic larynx [1] and the Withers et al report pertaining to the cumulative experience in 676 patients with tonsillar carcinoma pooled from nine institutions [2]. With regard to the latter, there was sufficient heterogeneity in staging evaluations, patient populations, treatment techniques, and other undocumented potential determinants of tumor control among the institutions that conclusions from such an analysis necessitate prospective confirmation.

As for the Wall et al analysis, a statistically significant (ie, P value equal to or less than .05) correlation between lymph node status and primary tumor control was found only after subgroup analysis and was limited to patients with T3 and T4 lesions and single or multiple lymph nodes(s) more than 3 cm. In addition, the analysis did not account for primary tumor volume and its potential relationship to extent of neck disease, a quantitative factor only recently found to be predictive of local tumor control in supraglottic and other head and neck carcinomas, and perhaps more sensitive than T stage [3,4].

In the Setting of Postoperative Therapy

The authors also present the results of four reviews, involving over 2,000 patients, that have addressed the question, does neck stage significantly predict local control after surgery, with or without radiotherapy? Of the four series, three showed no correlation between neck stage and local control. The inverse correlation found in the Hahn et al experience in patients with carcinomas of the supraglottis and pyriform sinus was a global finding of their entire series, which was not stratified according to T stage, primary site, or treatment group [5].

In our own recently reported experience of 57 patients with advanced squamous cell carcinomas of the head and neck, all of whom underwent resection of the primary lesion, neck dissection, and postoperative radiotherapy, multivariate analysis found only margin status (P = .002) and tumor grade (P = .007) to be significantly related to local control. Neither the presence of pathologically positive nodes nor neck stage was related to local control [6].

Summary

Based on the comprehensive review by Mendenhall et al, as well as our own experience, we conclude that currently there are no significant data showing a correlation between neck stage and local control at the primary tumor site following irradiation of head and neck carcinoma in both the definitive and postoperative setting.

A mechanism by which this issue may perhaps be better addressed is by archiving and analyzing the available database(s) from previous or ongoing prospective studies in which patients were staged and treated in a uniform manner. In the setting of postoperative therapy, an example of such a study would be the Radiation Therapy Oncology Group (RTOG) Trial 73-03, a prospective randomized study evaluating preoperative vs postoperative radiotherapy in patients with advanced head and neck carcinoma [7]. In addition, the existing RTOG database of over 2,000 patients with head and neck cancer, which has recently been analyzed with regard to the issue of staging prognostication, may be useful in addressing the issue of neck stage correlating with local control in the setting of definitive therapy [8].

In the meantime, like Mendenhahl et al, we also do not recommend a change in primary treatment philosophy for primary tumors based solely on the extent of nodal involvement in the neck.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



William M. Mendenhall, MD, James T. Parsons, MD, and Dietmar W. Siemann, PhD


1.Wall TJ, Peters LJ, Brown BW, et al: Relationship between lymph node status and primary tumor control probability in tumors of the supraglottic larynx. Int J Radiat Oncol Biol Physiol 11:1895-1902, 1985.

2. Withers HR, Peters LJ, Taylor MGJ, et al: Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Physiol 33(3):549-562, 1995.

3. Freeman DE, Mancuso AA, Parson JT, et al: Irradiation alone for supraglottic larynx carcinoma: Can CT findings predict treatment results? Int J Radiat Oncol Biol Physiol 19:485-490, 1990.

4. Johnson CR, Khandelwal SR, Schmidt-Ullrich RK, et al: The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int J Radiat Oncol Biol Physiol 32(3):635-641, 1995.

5. Hahn SS, Spaulding CA, Kim JA, Constable WC: The prognostic significance of lymph node involvement in pyriform sinus and supraglottic cancers. Int J Radiat Oncol Biol Physiol 13:1143-1147, 1987.

6. Rudoltz MS, Benammar A, Mohiuddin M: Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy? Int J Radiat Oncol Biol Physiol 31(3):503-508, 1995.

7. Tupchong L, Scott CB, Blitzer PH, et al: Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long term follow-up of RTOG Study 73-03. Int J Radiat Oncol Biol Physiol 20:21-28, 1991.

8. Cooper JS, Farnan NC, Asbell SO, et al: A comparison of RPA-derived staging and AJC staging in head and neck cancers based on RTOG data. Int J Radiat Oncol Biol Physiol 32(1):275, 1995.



 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy